These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31441730)

  • 21. Correlation of Serum Erythropoietin Levels with Different Stages of Diabetic Retinopathy.
    Muhammad TG; Haroon ZH; Younas M; Munir MU; Mukhtar MA; Anwar M
    J Coll Physicians Surg Pak; 2023 Apr; 33(4):380-384. PubMed ID: 37190707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of vasohibin-1 in type 2 diabetes mellitus patients with diabetic retinopathy.
    Feng Y; Wang D; Liu Y; Pang X; Zhang H
    Eur J Ophthalmol; 2022 Sep; 32(5):2864-2869. PubMed ID: 35001686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of serum N(ε)-Carboxy methyl lysine with severity of diabetic retinopathy.
    Mishra N; Saxena S; Shukla RK; Singh V; Meyer CH; Kruzliak P; Khanna VK
    J Diabetes Complications; 2016 Apr; 30(3):511-7. PubMed ID: 26782022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased serum periostin concentrations are associated with the presence of diabetic retinopathy in patients with type 2 diabetes mellitus.
    Ding Y; Ge Q; Qu H; Feng Z; Long J; Wei Q; Zhou Q; Wu R; Yao L; Deng H
    J Endocrinol Invest; 2018 Aug; 41(8):937-945. PubMed ID: 29349642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum cortisol is a biomolecular biomarker for severity of diabetic retinopathy.
    Mohan A; Saxena S; Kaur A; Ali W; Akduman L
    Mol Vis; 2021; 27():429-437. PubMed ID: 34267498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation, haemostatic disturbance, and obesity: possible link to pathogenesis of diabetic retinopathy in type 2 diabetes.
    Tomić M; Ljubić S; Kaštelan S; Gverović Antunica A; Jazbec A; Poljičanin T
    Mediators Inflamm; 2013; 2013():818671. PubMed ID: 24363502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy.
    Bonfiglio V; Platania CBM; Lazzara F; Conti F; Pizzo C; Reibaldi M; Russo A; Fallico M; Ortisi E; Pignatelli F; Longo A; Avitabile T; Drago F; Bucolo C
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Risk Factors for Diabetic Retinopathy in a Chinese Population: A Cross-Sectional Study.
    Sun Q; Jing Y; Zhang B; Gu T; Meng R; Sun J; Zhu D; Wang Y
    J Diabetes Res; 2021; 2021():5340453. PubMed ID: 33575359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum and tear levels of nerve growth factor in diabetic retinopathy patients.
    Park KS; Kim SS; Kim JC; Kim HC; Im YS; Ahn CW; Lee HK
    Am J Ophthalmol; 2008 Mar; 145(3):432-7. PubMed ID: 18282491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma
    Jiang Q; Lyu XM; Yuan Y; Wang L
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28108673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of hyperglycemia-mediated erythrocyte redox state alteration in the development of diabetic retinopathy.
    Choudhuri S; Mandal LK; Paine SK; Sen A; Dutta D; Chowdhury IH; Mukherjee A; Saha A; Bhadhuri G; Bhattacharya B
    Retina; 2013 Jan; 33(1):207-16. PubMed ID: 22653543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diabetes self-management and its association with diabetic retinopathy in patients with type 2 diabetes].
    Li N; Yang XF; Deng Y; Gu H; Ren XT; Xu J; Ma K; Liu NP
    Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):500-6. PubMed ID: 24119962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children.
    Zorena K; Myśliwska J; Myśliwiec M; Balcerska A; Hak Ł; Lipowski P; Raczyńska K
    Mediators Inflamm; 2007; 2007():92196. PubMed ID: 17641733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between diabetic retinopathy and plasma levels of high-sensitive C-reactive protein or von Willebrand factor in long-term type 1 diabetic patients.
    Laursen JV; Hoffmann SS; Green A; Nybo M; Sjølie AK; Grauslund J
    Curr Eye Res; 2013 Jan; 38(1):174-9. PubMed ID: 22906118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A decrease in VEGF and inflammatory markers is associated with diabetic proliferative retinopathy.
    Blum A; Socea D; Ben-Shushan RS; Keinan-Boker L; Naftali M; Segol G; Tamir S
    Eur Cytokine Netw; 2012; 23(4):158-62. PubMed ID: 23328414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between Cystatin C and retinopathy of type-two diabetes mellitus patients.
    Qian C; Wan GM; Yan PS; Wang WZ; Liang SZ; Dong Y
    J Biol Regul Homeost Agents; 2017; 31(1):99-103. PubMed ID: 28337877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D insufficiency in diabetic retinopathy.
    Payne JF; Ray R; Watson DG; Delille C; Rimler E; Cleveland J; Lynn MJ; Tangpricha V; Srivastava SK
    Endocr Pract; 2012; 18(2):185-93. PubMed ID: 21940279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered circulating mitochondrial DNA and increased inflammation in patients with diabetic retinopathy.
    Malik AN; Parsade CK; Ajaz S; Crosby-Nwaobi R; Gnudi L; Czajka A; Sivaprasad S
    Diabetes Res Clin Pract; 2015 Dec; 110(3):257-65. PubMed ID: 26625720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma Apolipoproteins Predicting the Occurrence and Severity of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus.
    Zhang X; Nie Y; Gong Z; Zhu M; Qiu B; Wang Q
    Front Endocrinol (Lausanne); 2022; 13():915575. PubMed ID: 35937834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Body mass index: a risk factor for retinopathy in type 2 diabetic patients.
    Kaštelan S; Tomić M; Gverović Antunica A; Ljubić S; Salopek Rabatić J; Karabatić M
    Mediators Inflamm; 2013; 2013():436329. PubMed ID: 24347825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.